Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.
- DOI
- 10.1038/s41467-026-75117-2
- Published
- 2026 Jul 8
- Container
- Nature communications
- Publisher
- Not recorded
- Open access
- yes
Credibility signals
limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- supportingOpen access status: Normalized open-access status: open.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.1038/s41467-026-75117-2,
title = {Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.},
author = {Best S and Hippe DS and Grunblatt E and Fatherree J and Chanana P and Wu F and Ivey R and Kennedy JJ and Sokolov D and Ibrahim A and Xu H and Monnat RJ Jr and Sullivan LB and Paddison P and Paulovich AG and MacPherson D},
year = {2026},
journal = {Nature communications},
doi = {10.1038/s41467-026-75117-2},
url = {https://doi.org/10.1038/s41467-026-75117-2}
}RIS
TY - JOUR TI - Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer. AU - Best S AU - Hippe DS AU - Grunblatt E AU - Fatherree J AU - Chanana P AU - Wu F AU - Ivey R AU - Kennedy JJ AU - Sokolov D AU - Ibrahim A AU - Xu H AU - Monnat RJ Jr AU - Sullivan LB AU - Paddison P AU - Paulovich AG AU - MacPherson D PY - 2026 JO - Nature communications DO - 10.1038/s41467-026-75117-2 UR - https://doi.org/10.1038/s41467-026-75117-2 ER -
APA
S, B., DS, H., E, G., J, F., P, C., F, W., R, I., JJ, K., D, S., A, I., H, X., Jr, M. R., LB, S., P, P., AG, P., & D, M. (2026). Loss of the USP22 deubiquitylase confers resistance to chemotherapy in small cell lung cancer.. Nature communications. https://doi.org/10.1038/s41467-026-75117-2
Source records
- pubmed · retrieved 2026-09-25T18:00:01.482Z